- Home
- RR vs ENGN Comparison
RR vs ENGN Comparison
Compare RR & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RR
- ENGN
- Stock Information
- Founded
- RR 2016
- ENGN 1999
- Country
- RR United States
- ENGN Canada
- Employees
- RR N/A
- ENGN N/A
- Industry
- RR
- ENGN
- Sector
- RR
- ENGN
- Exchange
- RR Nasdaq
- ENGN Nasdaq
- Market Cap
- RR 276.7M
- ENGN 317.6M
- IPO Year
- RR 2023
- ENGN N/A
- Fundamental
- Price
- RR $3.10
- ENGN $7.33
- Analyst Decision
- RR
- ENGN Strong Buy
- Analyst Count
- RR 0
- ENGN 9
- Target Price
- RR N/A
- ENGN $29.78
- AVG Volume (30 Days)
- RR 36.7M
- ENGN 112.9K
- Earning Date
- RR 01-14-2025
- ENGN 03-10-2025
- Dividend Yield
- RR N/A
- ENGN N/A
- EPS Growth
- RR N/A
- ENGN N/A
- EPS
- RR N/A
- ENGN N/A
- Revenue
- RR $4,240,000.00
- ENGN N/A
- Revenue This Year
- RR N/A
- ENGN N/A
- Revenue Next Year
- RR N/A
- ENGN N/A
- P/E Ratio
- RR N/A
- ENGN N/A
- Revenue Growth
- RR N/A
- ENGN N/A
- 52 Week Low
- RR $0.30
- ENGN $4.42
- 52 Week High
- RR $12.29
- ENGN $18.40
- Technical
- Relative Strength Index (RSI)
- RR 57.63
- ENGN 43.95
- Support Level
- RR $2.60
- ENGN $7.00
- Resistance Level
- RR $3.48
- ENGN $8.40
- Average True Range (ATR)
- RR 0.91
- ENGN 1.00
- MACD
- RR -0.06
- ENGN 0.02
- Stochastic Oscillator
- RR 34.98
- ENGN 32.13
About RR Richtech Robotics Inc. Class B
Richtech Robotics Inc is a developer of new robotic technologies focused on transforming labor-intensive services in hospitality and other sectors currently experiencing unprecedented labor shortages. The company designed, manufacture and sell robots to restaurants, hotels, senior living centers, casinos, factories, movie theaters and other businesses. Its robots perform a variety of services including restaurant running and bussing, hotel room service delivery, floor scrubbing and vacuuming, and beverage and food preparation. The company designs its robots to be friendly, customizable to client environments, and extremely reliable.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.